When it comes to drug access, should children be considered small adults? Countering coverage denials of FLT3 inhibitors in children with FLT3-ITD AML.
Tristan E KnightYubin GeJeffrey W TaubJohann K HitzlerJoerg KruegerPublished in: Pediatric blood & cancer (2021)